Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 7.9 EUR -0.75% Market Closed
Market Cap: 221.2m EUR

Wall Street
Price Targets

HYL Price Targets Summary
Hyloris Pharmaceuticals SA

Wall Street analysts forecast HYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYL is 13.84 EUR with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.

Lowest
Price Target
6.06 EUR
23% Downside
Average
Price Target
13.84 EUR
75% Upside
Highest
Price Target
21.42 EUR
171% Upside
Hyloris Pharmaceuticals SA Competitors:
Price Targets
ORNBV
Orion Oyj
2% Downside
600085
Beijing Tongrentang Co Ltd
36% Upside
200670
Humedix Co Ltd
73% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
2% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
45% Upside
AJANTPHARM
Ajanta Pharma Ltd
17% Upside
AHEALTH
Apex Healthcare Bhd
25% Downside

Revenue
Forecast

Revenue Estimate
Hyloris Pharmaceuticals SA

For the last 6 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 113%. The projected CAGR for the next 3 years is 101%.

113%
Past Growth
101%
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Net Income
Forecast

Net Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HYL's stock price target?
Price Target
13.84 EUR

According to Wall Street analysts, the average 1-year price target for HYL is 13.84 EUR with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.

What is Hyloris Pharmaceuticals SA's Revenue forecast?
Projected CAGR
101%

For the last 6 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 113%. The projected CAGR for the next 3 years is 101%.

Back to Top